undamentalytics Newsletter
Sign in

Oscar Health, Inc. income statement

In fiscal 2025, Oscar Health, Inc. reported revenue of $11.70bn, up 27.5% on the year before, operating income of −$396m (a -3.4% margin) and net income of −$443m, or −$1.69 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ billions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue0.50.51.84.05.99.211.715.3
Selling, general and administrative———1.31.41.82.02.4
General and administrative0.10.20.3—————
Operating income−0.3−0.4−0.5−0.6−0.20.1−0.40.6
Interest expense0.00.00.00.00.00.00.00.0
Income before tax−0.3−0.4−0.6−0.6−0.30.0−0.40.6
Income tax0.00.00.0−0.00.00.00.00.0
Net income−0.3−0.4−0.6−0.6−0.30.0−0.40.6
Diluted EPS−$9.06−$14.16−$3.20−$2.85−$1.22$0.10−$1.69$1.91
Diluted shares (average)29m29m179m212m222m266m262m288m
EBITDA−0.3−0.4−0.5−0.6−0.20.1−0.40.7

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: MOH vs OSCRALHC vs OSCRCLOV vs OSCR

More: Managed Health Care stocks compared, Health Care sector, rankings of US companies

Figures from Oscar Health, Inc.'s SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Oscar Health, Inc.